Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents

J Neurol Sci. 2022 Nov 15:442:120422. doi: 10.1016/j.jns.2022.120422. Epub 2022 Sep 15.

Affiliations

¹ Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
² Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Napoli, Italy.
³ Section of Neuroradiology, Santa Maria della Misericordia Hospital, Perugia, Italy.
⁴ Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy. Electronic address: [email protected].

PMID: 36162167
DOI: 10.1016/j.jns.2022.120422

No abstract available

Keywords: Gadolinium; MRI; Multiple sclerosis.

Publication types

Letter
Comment

MeSH terms

Brain / diagnostic imaging
Contrast Media*
Gadolinium
Humans
Magnetic Resonance Imaging
Multiple Sclerosis* / diagnostic imaging

Substances

Contrast Media
Gadolinium